Hypertension in 2010: Blood pressure and the kidney.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Renal nerve ablation reduces blood pressure in resistant hypertension: Long-term clinical outcomes in a single-center experience.Journal of clinical hypertension (Greenwich, Conn.) · 2018
   Article
2. Assessing murine resistance artery function using pressure myography.Journal of visualized experiments : JoVE · 2013
   Article
3. Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling.Current hypertension reports · 2013
   Article
4. Angiotensin II AT(2) receptor decreases AT(1) receptor expression and function via nitric oxide/cGMP/Sp1 in renal proximal tubule cells from Wistar-Kyoto rats.Journal of hypertension · 2012
   Article
5. Genetic modifiers of hypertension in soluble guanylate cyclase α1-deficient mice.The Journal of clinical investigation · 2012
   Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

Indexed as